Corporate News
Half-year Report
19 September 2023
MyHealthChecked PLC, the consumer home-testing healthcare company, announces its unaudited half-year report for the six months ended 30 June 2023.
Download To view a full version of the results in |
Financial highlights
- Revenue of £2.5m (H1 2022: £9.8m)
- Adjusted EBITDA loss £296,000 (H1 2022: £372,000 profit)
- Cash balance of £5m available to self-fund next growth phase
Commercial and operational highlights
- Launch of an extensive range of wellness tests into the UK’s top pharmacy retailer
- Investment in IT infrastructure to support customer journey of extensive range of blood and urine tests
- H1 investment in stockholding (£1.7m) to meet 2023 demand
- Achievement of Healthcare Inspectorate Wales accreditation
- Cyber Essentials Plus renewed for digital security
- Operational streamlining to minimise cash burn
- Appointment of Amber Vodegel as a Non-Executive Director post-period end
Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: “Despite the reduction in demand for COVID testing during the period under review, we have been very pleased with the delivery and retail launch of a broad range of blood and urine tests, progress with the capabilities of our digital platform, regulatory approval of our portfolio under CE marking, and achievement of Healthcare Inspectorate Wales accreditation.
“Post-period end we have seen increased demand for COVID testing as we move towards the winter season, and the Eris and Pirola strains are in the news. We remain well-placed to provide a reliable and effective supply chain at large volumes to retail.
“During the period we have further demonstrated the Company’s agile and ambitious capabilities and are poised to build awareness of this vast new range of tests in a dynamic category, whilst making progress in this new and exciting sector.”
Investor presentation
Penny McCormick, Chief Executive Officer and Adam Reynolds, Chairman will provide a live presentation relating to the Half-Year Report via the Investor Meet Company platform on Tuesday 19 September 2023 at 4.30pm. The presentation is open to all existing and potential shareholders.
Investors can sign up to Investor Meet Company for free and register for the presentation via the link below:
https://www.investormeetcompany.com/myhealthchecked-plc/register-investor
| MyHealthChecked PLC | www.myhealthcheckedplc.com | |
| Adam Reynolds, Chairman Penny McCormick, Chief Executive Officer | via Walbrook PR | |
| SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
| Neil Baldwin / Jade Bayat | ||
| Dowgate Capital Limited (Broker) | Tel: +44 (0)20 3903 7715 | |
| David Poutney / Nicholas Chambers | ||
| Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
| Paul McManus / Alice Woodings | Mob: +44(0)7980 541 893 / +44(0)7407 804 654 | |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.